↓ Skip to main content

Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing

Overview of attention for article published in Molecular Cancer, March 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
twitter
8 X users
patent
1 patent
wikipedia
1 Wikipedia page
video
1 YouTube creator

Citations

dimensions_citation
101 Dimensions

Readers on

mendeley
225 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
Published in
Molecular Cancer, March 2022
DOI 10.1186/s12943-022-01559-z
Pubmed ID
Authors

Alexander Dimitri, Friederike Herbst, Joseph A. Fraietta

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 225 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 225 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 24 11%
Student > Master 22 10%
Researcher 21 9%
Student > Ph. D. Student 18 8%
Unspecified 12 5%
Other 15 7%
Unknown 113 50%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 46 20%
Immunology and Microbiology 14 6%
Unspecified 13 6%
Agricultural and Biological Sciences 10 4%
Engineering 6 3%
Other 17 8%
Unknown 119 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2024.
All research outputs
#1,450,720
of 25,608,265 outputs
Outputs from Molecular Cancer
#79
of 1,939 outputs
Outputs of similar age
#35,866
of 461,517 outputs
Outputs of similar age from Molecular Cancer
#8
of 61 outputs
Altmetric has tracked 25,608,265 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,939 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 461,517 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.